ARID1A GENE MUTATION

Clinical trials for ARID1A GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new ARID1A GENE MUTATION trials appear

Sign up with your email to follow new studies for ARID1A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Terminated 1

Targeted drug trial seeks to control tumors driven by specific genetic flaw

Disease control Terminated

This study tested whether the drug tazemetostat could help control advanced solid tumors that have a specific genetic change called an ARID1A mutation. The drug was given to adult patients whose cancer had progressed after standard treatments. The goal was to see if blocking a re…

Matched conditions: ARID1A GENE MUTATION

Phase: PHASE2 • Sponsor: Prisma Health-Upstate • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ARID1A GENE MUTATION

Get alerted when new ARID1A GENE MUTATION trials appear

Targeted drug trial seeks to control tumors driven by specific genetic flaw